Remebot robot-assisted stereotactic electroencephalography electrode implantation in patients with medically-refractory epilepsy
10.3760/cma.j.cn115354-20220526-00367
- VernacularTitle:睿米手术机器人辅助下SEEG电极植入术在药物难治性癫痫中的临床应用
- Author:
Xueke ZHEN
1
;
Ying ZHANG
;
Hong TIAN
;
Li ZHANG
;
Yanbing YU
Author Information
1. 中日友好医院神经外科，北京 100029
- Keywords:
Remebot robot;
Stereotactic electroencephalography;
Medically-refractory epilepsy
- From:
Chinese Journal of Neuromedicine
2022;21(8):816-819
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical application value of frameless stereotactic electroencephalography (SEEG) electrode implantation assisted by domestic Remebot robot in patients with drug-refractory epilepsy.Methods:Ten patients with medically-refractory epilepsy, admitted to and accepted SEEG electrode implantation assisted by domestic Remebot robot in our hospital from October 2021 to March 2022, were chosen in our study. Epileptogenic focuses of these patients were determined. Bone Fiducial Markers were used for registration during surgery, and the registration error and implantation time of each electrode were recorded in detail. Thin-layer CT scan was performed immediately after surgery to observe the occurrence of complications. Three-dimensional reconstruction of all implanted electrodes was performed postoperatively, which was fused with the preoperative surgical planning paths and targets, and the electrode entry point error and target error were calculated.Results:SEEG electrodes were implanted in all 10 patients with the assistance of frameless surgical robot, and the resection areas were accurately determined according to the results of SEEG records. The registered error of these 10 patients was (0.24±0.03) mm. A total of 97 SEEG electrodes were implanted, and the average effective implantation time of each electrode was (6.3±1.2) min. After the fusion of three-dimensional electrode reconstruction with preoperative surgical plan, the mean entry point error of 97 electrodes was (1.9±1.2) mm, and the mean target error was (2.1±1.2) mm. Immediate postoperative head CT showed that none of the 10 patients had surgical complications such as intracranial hemorrhage or severe pneumoencephalos.Conclusion:The SEEG electrode implantation assisted by Remebot frameless robot is safe, accurate, and effective, which can meet the clinical needs.
